HLA Class I deficiency syndrome mimicking Wegener's granulomatosis

Arthritis and Rheumatism

Volumn 58, Issue 8, 2008, Pages 2579-2582

  Villa Forte, Alexandra ^a   De La Salle, Henri ^b   Fricker, Dominique ^c   Hentges, François ^d   Zimmer, Jacques ^d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; HLA ANTIGEN CLASS 1; HLA DR ANTIGEN; INFLIXIMAB; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;

ADULT; ANTIBIOTIC THERAPY; ANTIGEN PRESENTATION; ARTICLE; BRONCHIECTASIS; CASE REPORT; DIAGNOSTIC ERROR; DISEASE SEVERITY; DNA SEQUENCE; DRUG MEGADOSE; ENZYME ACTIVE SITE; FEMALE; FLOW CYTOMETRY; GENE MUTATION; GENETIC ANALYSIS; GENETIC COMPLEMENTATION; HLA CLASS 1 DEFICIENCY; HLA TYPING; HUMAN; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; LEG ULCER; OSTEOPOROSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; SINUSITIS; SKIN BIOPSY; STOP CODON; THORAX RADIOGRAPHY; TREATMENT RESPONSE; WEGENER GRANULOMATOSIS;

EID: 49449100182     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23675     Document Type: Article

References (13)

1. Gadola SD, Moins-Teisserenc HT, Trowsdale J, Gross WL, Cerundolo V. TAP deficiency syndrome. Clin Exp Immunol 2000;121:173-8.
2. De la Salle H, Zimmer J, Fricker D, Angenieux C, Cazenave JP, Okubo M, et al. HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. J Clin Invest 1999;103:R9-13.
3. Zimmer J, Andres E, Donato L, Hanau D, Hentges F, de la Salle H. Clinical and immunological aspects of HLA class I deficiency. QJM 2005;98:719-27.
4. Hoffman GS, Gross WL. Wegener's granulomatosis: clinical aspects. In: Hoffman GS, Weyand CM, editors. Inflammatory diseases of blood vessels. New York: Marcel Dekker; 2002. p. 381-97.
5. Abele R, Tampe R. The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing. Physiology (Bethesda) 2004;19:216-24.
6. Zimmer J, Bausinger H, Andres E, Donato L, Hanau D, Hentges F, et al. Phenotypic studies of natural killer cell subsets in human transporter associated with antigen processing deficiency. PLoS ONE 2007;2:e1033.
7. De la Salle H, Saulquin X, Mansour I, Klayme S, Fricker D, Zimmer J, et al. Asymptomatic deficiency in the peptide transporter associated to antigen processing. Clin Exp Immunol 2002;128:525-31.
8. De la Salle H, Houssaint E, Peyrat MA, Arnold D, Salamero J, Pinczon D, et al. Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens. J Immunol 1997;158:4555-63.
9. Parissiadis A, Dormoy A, Fricker D, Hanau D, de la Salle H, Cazenave JP, et al. Unilateral necrotising toxoplasmic retinochoroiditis as the main clinical manifestation of a peptide transporter (TAP) deficiency. Br J Ophthalmol 2005;89:1661-2.
10. Dogu F, Ikinciogullari A, Fricker D, Bozdogan G, Aytekin C, Ileri M, et al. A novel mutation for TAP deficiency and its possible association with toxoplasmosis. Parasitol Int 2006;55:219-22.
11. Moins-Teisserenc HT, Gadola SD, Cella M, Dunbar PR, Exley A, Blake N, et al. Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class I molecules. Lancet 1999;354:1598-603.
12. Soto A, Jorgensen C, Oksman F, Noel LH, Sany J. Endocarditis associated with ANCA. Clin Exp Rheumatol 1994;12:203-4.
13. Azuma A, Keicho N, Furukawa H, Yabe T, Kudoh S. Prolonged survival of a bare lymphocyte syndrome type I patient with diffuse panbronchiolitis treated with erythromycin. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:312-3.